Towards supporting greater and lower cost access to direct acting antiviral treatment for hepatitis C for all patients
Main Authors: | Said A Al-Busafi, Heba Omar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2017;volume=23;issue=4;spage=263;epage=264;aulast=Al-Busafi |
Similar Items
-
Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources
by: S. Marciano, et al.
Published: (2018-04-01) -
New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01) -
Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
by: Peter Karayiannis
Published: (2012-01-01) -
Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany
by: Melanie Runge, et al.
Published: (2020-01-01) -
Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.
by: Rakesh Aggarwal, et al.
Published: (2017-01-01)